Tactile Systems Technology, Inc. to Terminate Robert J. Folkes from the Position of Chief Operating Officer, Effective September 30, 2020
September 03, 2020 at 04:17 pm EDT
Share
Tactile Systems Technology, Inc. announced that in connection with a review of company's current management structure, it has determined to eliminate the position of Chief Operating Officer. On August 31, 2020, Robert J. Folkes was notified that he would be terminated from his position as company's Chief Operating Officer and as an employee, effective September 30, 2020.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company providing therapies for people with chronic disorders. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. The Company markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. The Company's Entre system is a basic pneumatic compression device. Kylee, its free mobile application, helps patients learn about lymphedema.
TACTILE SYSTEMS TECHNOLOGY, INC. 
